Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aastrom Biosciences Inc to acquire Sanofi 's Cell Therapy and Regenerative Medicine Business


Monday, 21 Apr 2014 08:31am EDT 

Aastrom Biosciences Inc:Agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine (CTRM) business.Purchase price of $6.5 mln, with $4 mln payable in cash at closing and $2.5 mln payable in form of a promissory note. 

Company Quote

95.86
0.51 +0.53%
24 Apr 2015